OverviewSuggest Edit

MRI Interventions, Inc., a medical device company, develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging guidance primarily in the United States. The company offers ClearPoint system, a neuro intervention system that is used to perform minimally invasive surgical procedures in the brain. It is also developing ClearTrace system, a cardiac intervention system for performing minimally invasive surgical procedures in the heart.
TypePublic
Founded1998
HQIrvine, US
Websitemriinterventions.com
Employee Ratings4

Latest Updates

Employees (est.) (Feb 2019)34
Revenue (FY, 2017)$7.4 M(+29%)

Key People/Management at MRI Interventions

Joseph M. Burnett

Joseph M. Burnett

CEO
Peter G. Piferi

Peter G. Piferi

COO
Harold A. Hurwitz

Harold A. Hurwitz

CFO
Show more

MRI Interventions Office Locations

MRI Interventions has an office in Irvine
Irvine, US (HQ)
5 Musick
Show all (1)
Report incorrect company information

MRI Interventions Financials and Metrics

MRI Interventions Revenue

MRI Interventions's revenue was reported to be $7.38 m in FY, 2017
USD

Revenue (Q3, 2018)

1.8m

Gross profit (Q3, 2018)

1.3m

Gross profit margin (Q3, 2018), %

69.4%

Net income (Q3, 2018)

(1.4m)

EBIT (Q3, 2018)

(1.2m)

Market capitalization (8-Oct-2018)

21.5m

Cash (30-Sep-2018)

3.7m
MRI Interventions's current market capitalization is $21.5 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

3.9m3.6m4.6m5.7m7.4m

Revenue growth, %

(8%)27%25%

Cost of goods sold

2.9m

Gross profit

4.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

927.5k822.5k1.2m633.2k1.0m825.7k1.2m1.4m1.1m1.6m2.0m2.0m1.7m1.6m1.6m1.8m

Cost of goods sold

589.0k602.2k553.2k

Gross profit

1.0m1.0m1.3m

Gross profit Margin, %

64%63%69%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

3.5m9.2m5.4m3.3m9.3m

Accounts Receivable

770.4k468.9k1.2m865.9k949.4k

Inventories

1.5m29.2k1.8m1.8m2.3m

Current Assets

5.9m11.7m8.5m6.1m12.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

5.0m5.8m4.1m1.9m6.4m3.5m1.9m3.6m2.0m4.4m2.0m12.7m11.0m7.5m6.7m3.7m

Accounts Receivable

787.7k452.7k599.1k548.8k605.7k487.1k837.4k1.5m769.7k803.5k1.0m750.8k910.1k770.8k1.1m

Inventories

1.2m1.7m1.9m2.3m2.1m2.1m1.8m1.6m1.6m1.8m1.8m1.9m2.2m2.5m2.7m2.5m

Current Assets

7.2m8.0m6.7m4.7m9.2m6.3m4.6m6.8m4.7m7.6m4.9m15.7m14.3m11.1m10.5m7.5m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(7.1m)(4.5m)(8.4m)(8.1m)(7.2m)

Depreciation and Amortization

211.9k155.7k116.5k

Inventories

(309.6k)145.7k68.6k72.3k(469.9k)

Accounts Payable

(695.3k)1.1m(436.4k)178.4k(512.4k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(5.4m)2.6m1.0m(2.6m)(3.9m)(7.0m)(7.3m)(2.0m)(3.8m)(6.4m)(1.7m)(3.7m)(5.1m)(1.6m)(3.5m)(4.9m)

Depreciation and Amortization

41.0k88.7k125.1k36.1k65.8k92.7k31.6k55.4k81.2k

Inventories

(355.7k)(147.9k)(299.6k)(657.9k)(188.1k)84.0k217.9k51.5k(34.0k)(62.0k)

Accounts Payable

(678.0k)(85.7k)677.0k1.2m1.1m(885.8k)(778.0k)52.8k(193.1k)(220.3k)5.1k(279.4k)(270.5k)(500.9k)(197.9k)(361.9k)
USDY, 2018

Financial Leverage

3.5 x
Show all financial metrics
Report incorrect company information

MRI Interventions Online and Social Media Presence

Embed Graph
Report incorrect company information

MRI Interventions News and Updates

MRI Interventions Reports 36% Increase in Fourth Quarter Revenue and Record Quarterly ClearPoint® Cases

Fourth Quarter Cash Burn from Operations Reduced to $600,000 Fourth Quarter Cash Burn from Operations Reduced to $600,000

MRI Interventions, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 11

IRVINE, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed to deliver navigation, ablation, deep brain stimulation, biopsy and gene therapy, today announced that it will release financial results for its 2018 four…

MRI Interventions to Host Meetings at Roth Capital Conference on March 18

IRVINE, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures for deep brain stimulation, ablation, aspiration and gene therapy, today announced that Joe Burnett, CEO, will host investor …

MRI Interventions Congratulates Voyager Therapeutics on First Patient Dosing in RESTORE-1, the Phase 2 VY-AADC Gene Therapy Trial for Parkinson’s Disease

IRVINE, Calif. , Dec. 10, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation, ablation and gene therapy, today announced participation in the RESTORE-1 gene therapy trial for Parkinson’s disease sponsored by Voyager …

MRI Interventions Reports Record ClearPoint® Cases and Disposable Functional Neurosurgery Revenue in Third Quarter

IRVINE, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) (the “Company”) today announced financial results for its third fiscal quarter ended September 30, 2018.

MRI Interventions and Clinical Laserthermia Systems (CLS) Announce Collaboration to Develop Next-Generation Navigation and Laser Ablation Platforms for Neurosurgery -- UPDATE

Under the terms of the agreement, MRIC acquires worldwide exclusive rights to the platform for use in Neurosurgery and Spine with CLS as manufacturer
Show more
Report incorrect company information

MRI Interventions Blogs

MRI Interventions Congratulates Dr. Clark Chen On First Patient Dosing In Minnesota For Phase 2 Glioblastoma Trial

IRVINE, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company developing products designed for navigation, ablation, deep brain stimulation, biopsy, aspiration and gene therapy, today congratulates Dr. Clark Chen on the first patient trea…

MRI Interventions Announces Collaboration with Voyager Therapeutics for the Design, Manufacture and Supply of V-TAG™ Device

IRVINE, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) a platform neurosurgery company developing products designed to deliver navigation, ablation, deep brain stimulation, aspiration, biopsy and gene therapy today announced a collaboration with Voyager Therapeuti…

MRI Interventions Announces Agreement with Siemens Healthineers For Interfacing with the Portfolio of Magnetom MRI Scanners

Agreement Enables the Development of More Efficient Clinical Workflows, Advanced Functionality and Shorter Surgical Procedure Times In the MRI Suite IRVINE, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company developing products desig…

MRI Interventions Announces Estimated 30% Growth Driven by Record Revenue and Record ClearPoint® Procedure Volume in 2018 Fourth Quarter

IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures for deep brain stimulation, ablation, aspiration and gene therapy, today announced preliminary and unaudited results for the …

MRI Interventions Receives FDA Clearance for ClearPoint® PURSUIT™ Neuro Aspiration System

Limited Market Release Marks the First Internally Developed Therapeutic Product Added to the Company Portfolio IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures involving dee…

MRI Interventions Announces FDA Clearance of ClearPoint® 2.0 Next-Generation Software Platform

Initial Limited Market Release Shipments to Commence Immediately IRVINE, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced FDA clearance for the company’s latest software platform – ClearPoint® 2.0. The platform’s new features are designed to improve…
Show more

MRI Interventions Frequently Asked Questions

  • When was MRI Interventions founded?

    MRI Interventions was founded in 1998.

  • Who are MRI Interventions key executives?

    MRI Interventions's key executives are Joseph M. Burnett, Peter G. Piferi and Harold A. Hurwitz.

  • How many employees does MRI Interventions have?

    MRI Interventions has 34 employees.

  • What is MRI Interventions revenue?

    Latest MRI Interventions annual revenue is $7.4 m.

  • What is MRI Interventions revenue per employee?

    Latest MRI Interventions revenue per employee is $217 k.

  • Who are MRI Interventions competitors?

    Competitors of MRI Interventions include Sanovas, Integra LifeSciences and Glaukos.

  • Where is MRI Interventions headquarters?

    MRI Interventions headquarters is located at 5 Musick, Irvine.

  • Where are MRI Interventions offices?

    MRI Interventions has an office in Irvine.

  • How many offices does MRI Interventions have?

    MRI Interventions has 1 office.